A 1 adenosine receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S263210, C514S263220, C514S263230, C514S263340, C514S263350, C514S263360, C544S267000, C544S269000, C544S270000, C544S272000, C544S273000, C544S311000, C544S312000, C558S392000

Reexamination Certificate

active

10780296

ABSTRACT:
Compounds of the general formula (I) are described:wherein A is a 5- or 6-membered aromatic or heteroaromatic ring. Compositions comprising such compounds and methods of use thereof are also described.

REFERENCES:
patent: 2840559 (1958-06-01), Krantz, Jr. et al.
patent: 2887486 (1959-05-01), Leake et al.
patent: 3031451 (1962-04-01), Schlesinger et al.
patent: 3309271 (1967-03-01), Georges et al.
patent: 3317533 (1967-05-01), De Ridder
patent: 3961060 (1976-06-01), Fuxe
patent: 4092417 (1978-05-01), Credner et al.
patent: 4299832 (1981-11-01), Brown et al.
patent: 4378359 (1983-03-01), Chiodoni et al.
patent: 4548818 (1985-10-01), Kjellin et al.
patent: 4612315 (1986-09-01), Jacobson et al.
patent: 4622324 (1986-11-01), Klessing et al.
patent: 4696932 (1987-09-01), Jacobson et al.
patent: 4769377 (1988-09-01), Snyder et al.
patent: 4772607 (1988-09-01), Badger et al.
patent: 4868186 (1989-09-01), Franzone et al.
patent: 4879296 (1989-11-01), Daluge et al.
patent: 4968672 (1990-11-01), Jacobson et al.
patent: 4971972 (1990-11-01), Doll et al.
patent: 5032593 (1991-07-01), Rzeszotarski et al.
patent: 5066655 (1991-11-01), Olsson
patent: 5068236 (1991-11-01), Suzuki et al.
patent: 5208240 (1993-05-01), Peet et al.
patent: 5248770 (1993-09-01), Jacobson et al.
patent: 5256650 (1993-10-01), Peet et al.
patent: 5290782 (1994-03-01), Suzuki et al.
patent: 5296463 (1994-03-01), Lee et al.
patent: 5298508 (1994-03-01), Jacobson et al.
patent: 5314890 (1994-05-01), Agostini et al.
patent: 5340813 (1994-08-01), Klein et al.
patent: 5395836 (1995-03-01), Shimada et al.
patent: 5434150 (1995-07-01), Austel et al.
patent: 5447933 (1995-09-01), Suzuki et al.
patent: 5504090 (1996-04-01), Neely
patent: 5532368 (1996-07-01), Kufner-Muhl et al.
patent: 5543415 (1996-08-01), Suzuki et al.
patent: 5545627 (1996-08-01), Jacobson et al.
patent: 5714494 (1998-02-01), Connell et al.
patent: 5719279 (1998-02-01), Kufner-Muhl et al.
patent: 5733916 (1998-03-01), Neely
patent: 5739331 (1998-04-01), Thyrion et al.
patent: 5786360 (1998-07-01), Neely
patent: 5932557 (1999-08-01), Mustafa et al.
patent: 6001842 (1999-12-01), Neely
patent: 6117445 (2000-09-01), Neely
patent: 2002/0058667 (2002-05-01), Castelhano et al.
patent: 2002/0082269 (2002-06-01), Neely
patent: 2002/0111333 (2002-08-01), Lin et al.
patent: 2003/0212082 (2003-11-01), Linden et al.
patent: 2004/0014766 (2004-01-01), Dunten et al.
patent: 2004/0110774 (2004-06-01), Wilson
patent: 2005/0187226 (2005-08-01), Wilson et al.
patent: 636 828 (1964-03-01), None
patent: 1 245 383 (1967-07-01), None
patent: 26 59 241 (1978-07-01), None
patent: 0 501 379 (1992-09-01), None
patent: 0 503 563 (1992-09-01), None
patent: 0 764 647 (1997-03-01), None
patent: 2 483 922 (1981-11-01), None
patent: 947495 (1964-01-01), None
patent: 9216883 (1997-08-01), None
patent: WO 98/03507 (1998-01-01), None
patent: WO 99/67239 (1999-12-01), None
patent: WO 01/34610 (2001-05-01), None
patent: WO 2003/028730 (2003-04-01), None
patent: WO 03/028730 (2003-10-01), None
patent: WO 2004/074247 (2004-09-01), None
patent: WO 2004/110379 (2004-12-01), None
patent: WO 2004110379 (2004-12-01), None
Belardinelli et al.,1, 3-Dipropyl-8-[2-(5, 6-Epoxy)Norbomyl]Xanthine, a Potent Specific and Selective A1Adenosine Receptor Antagonist in the Guinea Pig Heart and Brain and in DDT1MF-2 Cells, The Journal of Pharmacology and Experimental Therapeutics, vol. 276, No. 2:1167-1176 (1995).
Beauglehole et al.,New Irreversible Adenosine A1Antagonists Based on FSCPX, Bioorganic and Medicinal Chemistry Letters, 12:3179-3182 (2002).
Beauglehole et al.,Fluorosulfonyl-Substituted Xanthines as Selective Irreversible Antagonists for the A1-Adenosine Receptor, J. Med. Chem. 43:4973-4980 (2000).
Sonja Hess,Recent Advances in Adenosine Receptor Antagonist Research, Expert Opinion, Ashley Publications, 1354-3776 (2001).
Jacobson et al.,Adenosine Receptors: Pharmacology, Structure-Activity Relationships; and Therapeutic Potential, Journal of Medicinal Chemistry, vol. 35, No. 3:407-422 (Feb. 7, 1992).
Kuroda et al.,Design, Synthesis and Biological Evaluation of a Novel Series of Potent, Orally Active Adenosine A1Receptor Antagonists with High Blood-Brain Barrier Permeability, Chem. Pharm. Bull., 49:988-998 (2001).
Nicot et al.,High-Performance Liquid Chromatographic Method for the Determination of Bamifylline and it's Three Metabolites in Human Plasma, Journal of Chromatography, 277:239-249 (1983).
Novellino et al.,Design, Synthesis and Biological Evaluation of Novel N-Alkyl-and N-Acyl-(7-subsituted-2-2phenylimidazo[1.2-a] [1,3,5] triaxzin-4-yl] amines(ITAs)as Novel A1Adenosine Receptor Antagonists, J. Med. Chem. 45:5030-5036 (2002).
Sacchi et al.,Research on Heterocyclic Compounds. Part XXXVI. Imidazo[1,2-a]pyrimidine-a-acetic derivatives: synthesis and anti-inflammatory activity, Eur. J. Med. Chem., 32:677-682 (1997).
Scammells et al.,Substituted 1,3-Dipropylxanthines as Irreversible Antagonists of A1Adenosine Receptors, J. Med. Chem. 37:2704-2712 (1994).
Van Muijlwijk-Koezen et al.,Synthesis and Use of FSCPX, an Irreversible Adenosine A1Antagonist, as a ‘Receptor Knock-Down’ Tool, Bioorganic&Medicinal Chemistry Letters, 11:815-818 (2001).
Van Galen et al.,A Model for the Antagonist Binding Site on the Adenosine A1Receptor, Based on Steric, Electrostatic, and Hydrophobic Properties, J. Med. Chem., 33:1708-1713 (1990).
Van Tilburg et al.,Subsituted 4-Phenyl-2-2(phenylcarboxamido)-1,3-thiazole Derivatives as Antagonists for the Adenosine A1Receptor, Bioorganic&Medicinal Chemistry Letters, 11:2017-2019 (2001).
Wilson et al.,Lipopolysaccaride Binds to and Activates A1Adenosine Receptors on Human Pulmonary Artery Endothelial Cells, Journal of Endotoxin Research, vol. 8, No. 4:263-271 (2002).
Poulsen, Bioorganic & Medicinal Chem. Let, 6,619 (1998).
Foley, L.H. et al., “Modified 3-Alkyl-1, 8-dibenzylxanthines as GTP-Competitive Inhibitors of Phosphoenolpyruvate Carboxykinase,”Bioorganic&Medicinal Chemistry Letters, 2003, pp. 3607-3610, vol. 13.
Abbracchio, M.P. and F. Cattabeni, “Selective Activity of Bamifylline on Adenosine A1-Receptors in Rat Brain,”Pharmacological Research Communications, 1987, pp. 537-545, vol. 19(8).
Belliardo, F. and C. Lucarelli, “Micro-Scale Liquid Chromatographic Method for the Determination of Bamifylline and its Major Metabolite in Human Plasma,”Journal of Chromatography, 1990, pp. 305-309, vol. 535.
Carlucci, G., et al., “Determination of Bamifylline Hydrochloride Impurities in Bulk Material and Pharmaceutical Forms Using Liquid Chromatography with Ultraviolet Detection,”Journal of Pharmaceutical&Biomedical Analysis, 1990, pp. 1067-1069, vol. 8.
Jacobson, K.A., et al., “A Functionalized Congener Approach to Adenosine Receptor Antagonists: Amino Acid Conjugates of 1,3-Dipropylxanthine,”Molecular Pharmacology, 1985, pp. 126-133, vol. 29.
Jacobson, K.A., et al., “Electrophilic Derivatives of Purines as Irreversible Inhibitors of A1Adenosine Receptors,”Journal of Medicinal Chemistry, 1989, pp. 1043-1051, vol. 32.
Jacobson, K.A., et al., “Molecular Probes for Extracellular Adenosine Receptors,”Biochemical Pharmacology, 1987, pp. 1697-1707, vol. 36(10).
Müeller, C.E., et al., “7-Deaza-2-phenyladenines: Structure-Activity Relationships of Potent A1Selective Adenosine Receptor Antagonists,” 1990, pp. 2822-2828, vol. 33(10).
Neely, C.F., et al., “A1Adenosine Receptor Antagonists Block Ischemia-Reperfusion Injury of the Heart,”AHA-Circulation, Nov. 1996, pp. 1-5, 94(9).
Patel, A. et al., “I-BW-A844U, an Antagonist Radioligand with High Affinity and Selectivity for Adenosine A1Receptors, and125I-Azido-BW-A844U, a Photoaffinity Label,”Molecular Pharmacology, 1988, pp. 585-591, vol. 33.
Poulsen, S-A and R.J. Quinn, “Adenosine Receptors: New Opportunities for Future Drugs,”Bioorganic&Medicinal Chemistry, 1998, pp. 619-641, vol. 6.
Schiantarelli, P., et al., “Evidence of Pulmonary Tropism

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

A 1 adenosine receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A 1 adenosine receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A 1 adenosine receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3724910

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.